4//SEC Filing
Chanan-Khan Asher 4
Accession 0001104659-24-072875
CIK 0001279704other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 5:00 PM ET
Size
6.0 KB
Accession
0001104659-24-072875
Insider Transaction Report
Form 4
Chanan-Khan Asher
Director
Transactions
- Award
Stock option (right to buy)
2024-06-14+60,000→ 60,000 totalExercise: $2.58Exp: 2033-12-22→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024.
- [F2]This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
Cellectar Biosciences, Inc.
CIK 0001279704
Entity typeother
Related Parties
1- filerCIK 0001869837
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 5:00 PM ET
- Size
- 6.0 KB